BUSINESS

• Sumitomo Dainippon to Invest in, Conduct Joint R&D with Cyborg Tech Startup
  October 18, 2018

• Nippon Shinyaku Seeks Japan Approval for Hepatic VOD Treatment Defibrotide
  October 18, 2018

• Shionogi Launches New Manufacturing Subsidiary, Commencing Operations in April Next Year
  October 18, 2018

• Eisai’s Insomnia Treatment Lemborexant Smashes Primary Target in Long-Term PIII Study
  October 18, 2018

• Daiichi Sankyo Files Quizartinib for AML in Japan
  October 18, 2018

• JAK Inhibitor Battle for Atopic Dermatitis Intensifying, 1st Japan Filing Might Be Near
  October 17, 2018

• Eisai Seals Latin America Pact for Belviq
  October 17, 2018

• Teva Takeda Launches Voluntary Recall for Taxotere Generics
  October 17, 2018

• Chugai’s Satralizumab Cuts Relapse Risk of Neuromyelitis Optica Spectrum Disorder
  October 16, 2018

• Ono Joins GHIT Fund as 21st Funding Partner
  October 16, 2018

• China Regulators Accept NDA for Fycompa
  October 15, 2018

• Chugai Sues Daiichi Sankyo, Pfizer over Herceptin Biosimilars
  October 15, 2018

• Oncodesign Strengthens Its Cooperation with Eisai
  October 15, 2018

• Kyorin Begins Collaborative Research on Antibiotics with Microbial Chemistry Research Foundation
  October 12, 2018

• Nippon Shinyaku to Expand Contract Manufacturing Biz with New Facility to Start Full Operation in Feb.
  October 12, 2018

• Avastin Top-Seller in Japan for 2nd Straight Month in September: Encise Snapshot
  October 11, 2018

• Perjeta Gets Japan OK as Neoadjuvant, Adjuvant Therapy for HER2 Breast Cancer
  October 11, 2018

• Shonan iPark to Focus on Disease Prevention, 3 Other Areas, Aiming to House 200 Companies by FY2023
  October 11, 2018

• Towa’s Allegra Generic Grabs Approval for Expanded Pediatric Use
  October 11, 2018

• Opdivo/Yervoy Combo Gets 1st Line RCC Nod in South Korea
  October 10, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 377
• 378
• 379
• 380
• 381
• 382
• 383
• 384
• 385
• …
• Next ›
• 最終 »